The effect of water-soluble polymers on the aqueous solubility and complexing abilities of β-cyclodextrin

International Journal of Pharmaceutics

Volumn 163, Issue 1-2, 1998, Pages 115-121

  Loftsson, Thorsteinn ^a   Fririksdóttir, Hafrún ^a  

^a Inst Exp Pathol Univ I   (Iceland)

Author keywords

Complexation; Cyclodextrin; Drug delivery; Drug formulations; Polymers; Solubility

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ACETAZOLAMIDE; BETA CYCLODEXTRIN; CARBAMAZEPINE; CARBOXYMETHYLCELLULOSE; ECONAZOLE; GAMMA CYCLODEXTRIN; HYDROCORTISONE; HYDROXYPROPYLMETHYLCELLULOSE; METHAZOLAMIDE; POLYMER; POVIDONE;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG FORMULATION; DRUG SOLUBILITY; HYDROPHILICITY; POLYMERIZATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0344588867     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00371-2     Document Type: Article

References (14)

1. Duchêne, D. and Wouessidjewe, D., 1996. Pharmaceutical and medical applications of cyclodextrins. In: Dumitriu, S. (Ed.), Polysaccharides in Medical Applications. Marcel Dekker, New York, pp. 575-602.
2. Frömming, K.-H., Szejtli, J., 1994. CDs in Pharmacy. Kluwer Academic, Dordrecht.
3. Fujita H., Ooya T., Kurisawa M., Mori H., Terano M., Yui N. Thermally switchable polyrotaxane as a model of stimuli-responsive supramolecules for nano-scale devices. Macromol. Rapid Commun. 17:1996;509-515.
4. Ganzerli G., van Santvliet L., Verschuren E., Ludwig A. Influence of beta-cyclodextrin and various polysaccharides on the solubility of fluorescein and on the rheological and mucoadhesive properties of ophthalmic solutions. Pharmazie. 51:1996;357-362.
5. Higuchi T., Connors K.A. Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4:1965;117-121.
6. Hladon T., Cwiertinia B. Physical and chemical interactions between cellulose ethers and β-cyclodextrins. Pharmazie. 49:1994;497-500.
7. Irie T., Uekama K. Pharmaceutical applications of cyclodextrins. 3. Toxicological issues and safety evaluation. J. Pharm. Sci. 86:1997;147-162.
8. Loftsson T., Brewster M.E. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85:1996;1017-1025.
9. Loftsson T., Brewster M.E. Cyclodextrins as pharmaceutical excipients. Pharm. Technol. Eur. 9(5):1997;26-34.
10. Loftsson, T., Sigurardóttir, A.M., 1996. Cyclodextrins as skin penetration enhancers. In: Szejtli, J., Szente, L. (Eds.), Proceedings of the Eighth International Symposium on CDs. Kluwer Academic, Dordrecht, pp. 509-515.
11. Loftsson T., Fririksdóttir H., Sigurardóttir A.M., Ueda H. The effect of water-soluble polymers on drug-cyclodextrin complexation. Int. J. Pharm. 110:1994;169-177.
12. Rajewski R.A., Stella V.J. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J. Pharm. Sci. 85:1996;1142-1169.
13. Sigurardóttir A.M., Loftsson T. The effect of polyvinylpyrrolidone on cyclodextrin complexation of hydrocortisone and its diffusion through hairless mouse skin. Int. J. Pharm. 126:1995;73-78.
14. Szejtli, J., 1988. CD Technology. Kluwer Academic, Dordrecht, pp. 1-78.